Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-05

Clinical Trial Update: Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC) [Phase 3]

View source ↗

Summary

This entry describes a Phase 3 clinical trial evaluating the effect of simvastatin on prognosis in Primary Sclerosing Cholangitis (PSC), which is currently acti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Annika Bergquist | Conditions: Primary Sclerosing Cholangitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING